Akili Pays $37.5M To License Tali’s Tech For Early Childhood Attention Impairments

Tali’s video game assesses and improves attention in children three to eight years old. Akili markets the EndeavorRx prescription video game therapy to improve attention function in children ages eight to 12. The deal will help Tali commercialize its technology in the US.